Hepatic Pseudolesion
Focal Fatty Sparing
Focal Fatty Sparing refers to localized areas of normal liver parenchyma within a diffusely fatty liver. These regions appear relatively hypoechoic compared to the surrounding steatotic liver and commonly occur adjacent to the gallbladder fossa, porta hepatis, or falciform ligament. It is a benign finding and should not be mistaken for a focal hepatic mass.
Focal Fatty Sparing is a benign hepatic imaging finding characterized by localized regions of normal echogenicity within a background of diffuse hepatic steatosis. These spared areas commonly appear hypoechoic relative to the fatty liver and may mimic focal hepatic lesions on ultrasound. Typical locations include the gallbladder fossa, porta hepatis, and adjacent to the falciform ligament. Recognition of characteristic appearance and location helps avoid misdiagnosis.
Ultrasound Features of Focal Fatty Sparing:
Echogenicity: Hypoechoic area relative to the surrounding fatty liver parenchyma
Shape: Geographic, wedge-shaped, or irregular
Margins: Ill-defined and blending with adjacent liver tissue
Mass Effect: Absent
Vascular Architecture: Preserved
Color Doppler: Normal vascular flow pattern
Common Sites: Gallbladder fossa, porta hepatis, falciform ligament, periportal region
Key Diagnostic Clue: Normal portal and hepatic vessels traverse the region without displacement or distortion
Finding: Localized hypoechoic area is noted within the diffusely fatty liver parenchyma, consistent with focal fatty sparing. No focal hepatic mass lesion is identified. Normal vascular structures traverse the region without displacement or mass effect.
Impression: Focal fatty sparing within a background of diffuse hepatic steatosis. No suspicious focal hepatic lesion identified.
Recommendation: No specific follow-up is required when typical imaging features are present. Clinical correlation and liver function assessment may be considered. MRI may be performed in atypical cases or when diagnostic uncertainty persists.
Limitation: Assessment may be limited by obesity, overlying bowel gas, poor acoustic window, or severe diffuse hepatic steatosis, which may reduce lesion conspicuity and characterization.
Echogenicity: Hypoechoic area relative to the surrounding fatty liver parenchyma
Shape: Geographic, wedge-shaped, or irregular
Margins: Ill-defined and blending with adjacent liver tissue
Mass Effect: Absent
Vascular Architecture: Preserved
Color Doppler: Normal vascular flow pattern
Common Sites: Gallbladder fossa, porta hepatis, falciform ligament, periportal region
Key Diagnostic Clue: Normal portal and hepatic vessels traverse the region without displacement or distortion
Finding: Localized hypoechoic area is noted within the diffusely fatty liver parenchyma, consistent with focal fatty sparing. No focal hepatic mass lesion is identified. Normal vascular structures traverse the region without displacement or mass effect.
Impression: Focal fatty sparing within a background of diffuse hepatic steatosis. No suspicious focal hepatic lesion identified.
Recommendation: No specific follow-up is required when typical imaging features are present. Clinical correlation and liver function assessment may be considered. MRI may be performed in atypical cases or when diagnostic uncertainty persists.
Limitation: Assessment may be limited by obesity, overlying bowel gas, poor acoustic window, or severe diffuse hepatic steatosis, which may reduce lesion conspicuity and characterization.
MRI Features of Focal Fatty Sparing:
T1-Weighted Imaging: Isointense to normal liver parenchyma and relatively hypointense compared to fatty liver
T2-Weighted Imaging: Isointense or mildly hypointense relative to surrounding fatty liver
In-Phase / Opposed-Phase Imaging: No signal drop within the spared area; surrounding fatty liver shows signal loss on opposed-phase images
Diffusion-Weighted Imaging: No restricted diffusion
Contrast Enhancement: Enhancement pattern similar to normal liver parenchyma
Hepatobiliary Phase: Preserved uptake; no true focal defect
Shape: Geographic, wedge-shaped, or irregular
Margins: Ill-defined
Mass Effect: Absent
Vascular Architecture: Preserved; vessels traverse the area without displacement
Common Sites: Gallbladder fossa, falciform ligament, porta hepatis
Key Diagnostic Clue: Spared area does not lose signal on opposed-phase imaging while the surrounding fatty liver shows signal drop
Finding: Focal area showing no signal drop on opposed-phase imaging within a diffusely fatty liver, consistent with focal fatty sparing. No restricted diffusion or mass effect is identified.
Impression: MRI features are consistent with focal fatty sparing in a background of hepatic steatosis. No suspicious focal hepatic mass lesion identified.
Recommendation: No further imaging is required when MRI features are characteristic. Follow-up may be considered only if clinical suspicion persists.
Limitation: Evaluation may be limited by motion artifact, poor breath-holding, incomplete chemical shift sequences, or suboptimal contrast timing.
T1-Weighted Imaging: Isointense to normal liver parenchyma and relatively hypointense compared to fatty liver
T2-Weighted Imaging: Isointense or mildly hypointense relative to surrounding fatty liver
In-Phase / Opposed-Phase Imaging: No signal drop within the spared area; surrounding fatty liver shows signal loss on opposed-phase images
Diffusion-Weighted Imaging: No restricted diffusion
Contrast Enhancement: Enhancement pattern similar to normal liver parenchyma
Hepatobiliary Phase: Preserved uptake; no true focal defect
Shape: Geographic, wedge-shaped, or irregular
Margins: Ill-defined
Mass Effect: Absent
Vascular Architecture: Preserved; vessels traverse the area without displacement
Common Sites: Gallbladder fossa, falciform ligament, porta hepatis
Key Diagnostic Clue: Spared area does not lose signal on opposed-phase imaging while the surrounding fatty liver shows signal drop
Finding: Focal area showing no signal drop on opposed-phase imaging within a diffusely fatty liver, consistent with focal fatty sparing. No restricted diffusion or mass effect is identified.
Impression: MRI features are consistent with focal fatty sparing in a background of hepatic steatosis. No suspicious focal hepatic mass lesion identified.
Recommendation: No further imaging is required when MRI features are characteristic. Follow-up may be considered only if clinical suspicion persists.
Limitation: Evaluation may be limited by motion artifact, poor breath-holding, incomplete chemical shift sequences, or suboptimal contrast timing.
CECT Features of Focal Fatty Sparing:
Non-Contrast CT: Relatively hyperattenuating area compared to the surrounding fatty liver
Arterial Phase: No abnormal arterial enhancement
Portal Venous Phase: Relatively hyperattenuating region within diffusely hypoattenuating fatty liver
Delayed Phase: No washout or progressive enhancement
Shape: Geographic, wedge-shaped, or irregular
Margins: Ill-defined, blending with adjacent liver parenchyma
Mass Effect: Absent
Vascular Architecture: Preserved; normal vessels course through the region
Enhancement Pattern: Follows background liver enhancement without forming a discrete enhancing mass
Common Sites: Gallbladder fossa, falciform ligament, porta hepatis
Key Diagnostic Clue: Relatively hyperattenuating pseudolesion within fatty liver with no mass effect and preserved traversing vessels
Finding: Relatively hyperattenuating focal area is seen within the diffusely hypoattenuating fatty liver, showing no abnormal enhancement, washout, or mass effect. Vascular structures are preserved.
Impression: CECT features are suggestive of focal fatty sparing within diffuse hepatic steatosis. No suspicious enhancing hepatic mass lesion identified.
Recommendation: No specific follow-up is required if typical features are present. MRI chemical shift imaging may be considered if the lesion appears atypical.
Limitation: Assessment may be limited by single-phase imaging, suboptimal contrast timing, beam-hardening artifact, or severe diffuse steatosis.
Non-Contrast CT: Relatively hyperattenuating area compared to the surrounding fatty liver
Arterial Phase: No abnormal arterial enhancement
Portal Venous Phase: Relatively hyperattenuating region within diffusely hypoattenuating fatty liver
Delayed Phase: No washout or progressive enhancement
Shape: Geographic, wedge-shaped, or irregular
Margins: Ill-defined, blending with adjacent liver parenchyma
Mass Effect: Absent
Vascular Architecture: Preserved; normal vessels course through the region
Enhancement Pattern: Follows background liver enhancement without forming a discrete enhancing mass
Common Sites: Gallbladder fossa, falciform ligament, porta hepatis
Key Diagnostic Clue: Relatively hyperattenuating pseudolesion within fatty liver with no mass effect and preserved traversing vessels
Finding: Relatively hyperattenuating focal area is seen within the diffusely hypoattenuating fatty liver, showing no abnormal enhancement, washout, or mass effect. Vascular structures are preserved.
Impression: CECT features are suggestive of focal fatty sparing within diffuse hepatic steatosis. No suspicious enhancing hepatic mass lesion identified.
Recommendation: No specific follow-up is required if typical features are present. MRI chemical shift imaging may be considered if the lesion appears atypical.
Limitation: Assessment may be limited by single-phase imaging, suboptimal contrast timing, beam-hardening artifact, or severe diffuse steatosis.
Pathology Features of Focal Fatty Sparing:
Nature: Benign pseudolesion rather than a true hepatic mass
Background Liver: Diffuse hepatic steatosis with localized spared normal liver parenchyma
Cellular Change: Relative absence or marked reduction of intracellular fat in the spared area
Inflammation: Usually absent
Fibrosis: Usually absent unless there is associated chronic liver disease
Necrosis: Absent
Mass Formation: Absent
Vascular Architecture: Preserved normal hepatic vascular and biliary architecture
Clinical Significance: Benign imaging finding that may mimic a focal hepatic lesion
Key Diagnostic Clue: Normal liver tissue preserved within a diffusely fatty liver without tumor cells, architectural distortion, or mass effect
Finding: Pathologically, focal fatty sparing represents an area of relatively normal hepatic parenchyma within a diffusely steatotic liver. There is no true neoplastic mass formation.
Impression: Benign hepatic pseudolesion corresponding to focal preservation of normal liver parenchyma in diffuse hepatic steatosis.
Recommendation: Histopathological confirmation is usually not required when imaging features are characteristic. Biopsy is reserved for atypical lesions or cases with persistent diagnostic uncertainty.
Limitation: Pathology is not routinely available because focal fatty sparing is typically diagnosed radiologically. Sampling error may occur if biopsy is performed from a small or ill-defined region.
Nature: Benign pseudolesion rather than a true hepatic mass
Background Liver: Diffuse hepatic steatosis with localized spared normal liver parenchyma
Cellular Change: Relative absence or marked reduction of intracellular fat in the spared area
Inflammation: Usually absent
Fibrosis: Usually absent unless there is associated chronic liver disease
Necrosis: Absent
Mass Formation: Absent
Vascular Architecture: Preserved normal hepatic vascular and biliary architecture
Clinical Significance: Benign imaging finding that may mimic a focal hepatic lesion
Key Diagnostic Clue: Normal liver tissue preserved within a diffusely fatty liver without tumor cells, architectural distortion, or mass effect
Finding: Pathologically, focal fatty sparing represents an area of relatively normal hepatic parenchyma within a diffusely steatotic liver. There is no true neoplastic mass formation.
Impression: Benign hepatic pseudolesion corresponding to focal preservation of normal liver parenchyma in diffuse hepatic steatosis.
Recommendation: Histopathological confirmation is usually not required when imaging features are characteristic. Biopsy is reserved for atypical lesions or cases with persistent diagnostic uncertainty.
Limitation: Pathology is not routinely available because focal fatty sparing is typically diagnosed radiologically. Sampling error may occur if biopsy is performed from a small or ill-defined region.
Case Study
Patient: 52-year-old male undergoing evaluation for fatty liver disease.
Ultrasound Findings: Localized hypoechoic area adjacent to the gallbladder fossa within a diffusely fatty liver.
MRI Findings: No signal drop within the lesion on opposed-phase imaging while surrounding liver demonstrates signal loss.
Diagnosis: Focal Fatty Sparing.
Teaching Point: Absence of mass effect and normal vessels traversing the region are key features distinguishing focal fatty sparing from a true hepatic mass.
Patient: 52-year-old male undergoing evaluation for fatty liver disease.
Ultrasound Findings: Localized hypoechoic area adjacent to the gallbladder fossa within a diffusely fatty liver.
MRI Findings: No signal drop within the lesion on opposed-phase imaging while surrounding liver demonstrates signal loss.
Diagnosis: Focal Fatty Sparing.
Teaching Point: Absence of mass effect and normal vessels traversing the region are key features distinguishing focal fatty sparing from a true hepatic mass.
Video Explanation
SonoAcademy Digital MCQ Examination
Topic: Focal Fatty Sparing
Total Questions: 10 | Total Marks: 10 | Time: 30 Minutes
Instruction: Enter your details, start the exam, answer all questions, and download your PDF marksheet after submission.
Exam Result
Name:
Email / Mobile:
Topic: Focal Fatty Sparing
Total Marks: 10
Obtained Marks:
Percentage: %
Status:
No comments:
Post a Comment